2-[[2,4,6-トリヨード-3-[(1-オキソブチル)アミノ]フェニル]メチレン]ブタン酸 化学特性,用途語,生産方法
brand name
Bunaiod;Orabilex;Orabilix.
世界保健機関(WHO)
Bunamiodyl, an orally administered radio-opaque medium, was
introduced in 1958 for use in the examination of the biliary tract. By 1964 its use
had been associated with cases of renal failure, in some cases fatal, which resulted
in its withdrawal by the United States Food and Drug Administration. Buniamiodyl
was withdrawn worldwide by the manufacturer in 1984.
2-[[2,4,6-トリヨード-3-[(1-オキソブチル)アミノ]フェニル]メチレン]ブタン酸 上流と下流の製品情報
原材料
準備製品